VISTAGEN THERAPEUTICS, INC.
Cash Flow Statement
| Line Item | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-14.3M | $-10.3M | $-47.2M | $-13.9M | $-3.0M | $-12.9M | $-12.2M | $-9.5M |
| Depreciation & Amortization | $80.7K | $54.9K | $53.5K | $59.1K | $54.6K | $33.8K | $45.6K | $45.3K |
| Depreciation | — | — | — | — | — | — | — | — |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | — | — | — | $2.5M | $1.1M | $1.2M | $1.6M | $1.6M |
| Net Cash from Operating Activities | $-9.1M | $-7.3M | $-4.8M | $-2.8M | $-2.1M | $-3.5M | $-3.6M | $-841.3K |
| Investing Activities | ||||||||
| Capital Expenditures | $1.6K | $239.1K | $26.3K | — | — | — | — | — |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $-1.6K | $-239.1K | $-26.3K | — | $9.6K | $-135.4K | $-32.4K | $-57.8K |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $16.5M | — | — | $2.8M | $1.5M | $4.2M | $3.5M | $837.4K |
| Net Change in Cash | $7.5M | $2.5M | $358.5K | $70.0K | $-638.1K | $557.1K | $-58.3K | $-61.7K |
| Free Cash Flow | $-9.1M | $-7.5M | $-4.8M | — | — | — | — | — |